Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4606]

ASCO 2014: Adding lapatinib to adjuvant trastuzumab does not improve outcomes in early- stage HER2-positive breast cancer

ASCO 2014: Adding lapatinib to adjuvant trastuzumab does not improve outcomes in early- stage HER2-positive breast...

ASCO 2014: Second-line treatment with ramucirumab plus docetaxel extends survival in advanced NSCLC

ASCO 2014: Second-line treatment with ramucirumab plus docetaxel extends survival in advanced NSCLC

Guideline update recommends tamoxifen for up to 10 years for women with non-metastatic hormone receptor positive breast cancer

Guideline update recommends tamoxifen for up to 10 years for women with non-metastatic hormone receptor positive...

New blood-based biomarker panel may enable pancreatic cancer diagnosis at an early stage

New blood-based biomarker panel may enable pancreatic cancer diagnosis at an early stage

Research in several cancers reveals promising treatment strategies, new insights on screening, and obesity-cancer link

Research in several cancers reveals promising treatment strategies, new insights on screening, and obesity-cancer...

Delaying androgen deprivation therapy may be safe for men with prostate cancer relapse detected by PSA testing

Delaying androgen deprivation therapy may be safe for men with prostate cancer relapse detected by PSA testing

New EGFR inhibitor AZD9291 shows promising activity in treatment-resistant non-small cell lung cancer

New EGFR inhibitor AZD9291 shows promising activity in treatment-resistant non-small cell lung cancer

Obesity substantially increases breast cancer mortality only in women with pre-menopausal ER disease

Obesity substantially increases breast cancer mortality only in women with pre-menopausal ER disease

IMPAKT: Molecular subtype of a breast cancer relapse influences patient post-relapse survival

IMPAKT: Molecular subtype of a breast cancer relapse influences patient post-relapse survival

IMPAKT: Therapeutic effect and markers of response of palbociclib in HER2-positive breast cancer models

IMPAKT: Therapeutic effect and markers of response of palbociclib in HER2-positive breast cancer models

More from ecancer